Childhood autoimmune liver disease: Indications and outcome of liver transplantation

Journal of Pediatric Gastroenterology and Nutrition

Volumn 50, Issue 3, 2010, Pages 295-302

  Chai, Pei Fan ^a   Lee, Way Seah ^a   Brown, Rachel M ^b   McPartland, Jo L ^c   Foster, Katharine ^d   McKiernan, Patrick J ^b   Kelly, Deirdre A ^b  

^a UNIVERSITY MALAYA MEDICAL CENTRE   (Malaysia)

^b BIRMINGHAM CHILDREN S HOSPITAL   (United Kingdom)

^c ALDER HEY CHILDREN S HOSPITAL   (United Kingdom)

^d Department of Radiology ^*  (United States)

Author keywords

Autoimmune liver disease; Childhood; Liver transplant

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; AUTOANTIBODY; AZATHIOPRINE; CYCLOSPORIN; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE; STEROID; TACROLIMUS; URSODEOXYCHOLIC ACID;

ACUTE GRAFT REJECTION; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; AUTOIMMUNE DISEASE; AUTOIMMUNE HEPATITIS; CAUSE OF DEATH; CHILD; CHILDHOOD DISEASE; CHRONIC GRAFT REJECTION; CHRONIC HEPATITIS; COHORT ANALYSIS; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FEMALE; GRAFT FAILURE; HUMAN; HUMAN TISSUE; LIVER DISEASE; LIVER FAILURE; LIVER GRAFT REJECTION; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; OVERLAP SYNDROME; PEDIATRIC SURGERY; PRIORITY JOURNAL; PROTHROMBIN TIME; RECURRENCE RISK; RECURRENT DISEASE; RETRANSPLANTATION; RETROSPECTIVE STUDY; SCHOOL CHILD; SCLEROSING CHOLANGITIS; SEPSIS; STEROID THERAPY; SURGICAL MORTALITY; TREATMENT FAILURE; TREATMENT INDICATION; TREATMENT OUTCOME;

ALANINE TRANSAMINASE; ASPARTATE AMINOTRANSFERASES; CHILD; CHOLANGITIS, SCLEROSING; CYCLOSPORINE; FEMALE; GRAFT REJECTION; HEPATITIS, AUTOIMMUNE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LIVER; LIVER FAILURE, ACUTE; LIVER TRANSPLANTATION; MALE; PROTHROMBIN TIME; RECURRENCE; RETROSPECTIVE STUDIES; STEROIDS; SURVIVAL ANALYSIS; SURVIVAL RATE; SYNDROME; TACROLIMUS; TREATMENT OUTCOME;

EID: 77649307955     PISSN: 02772116     EISSN: None     Source Type: Journal    
DOI: 10.1097/MPG.0b013e3181bf0ef7     Document Type: Article

References (36)

1. Czaja AJ, Freese DK. Diagnosis and treatment of autoimmune hepatitis. Hepatology 2002;36:479-497
2. Mieli-Vergani G, Vergani D. Autoimmune pediatric liver disease.World J Gastroenterol 2008;14:3360-3367
3. Gregorio GV, Portmann B, Karani J, et al. Autoimmune hepatitis/ sclerosing cholangitis overlap syndrome: a 16-year prospective study. Hepatology 2001;33:544-553
4. Heneghan MA, McFarlane IG. Current and novel immunosuppressive therapy for autoimmune hepatitis. Hepatology 2002;35:7-13.
5. Aw MM, Dhawan A, Samyn M, et al. Mycophenolate mofetil as rescue treatment for autoimmune liver disease in children: a 5-year follow up. J Hepatol 2009;51:156-160
6. Gilger MA, Gann ME, Opekun AR, et al. Efficacy of ursodeoxycholic acid in the treatment of primary sclerosing cholangitis in children. J Pediatr Gastroenterol Nutr 2000;31:136-141
7. Czaja AJ, Carpenter HA, Santrach P, et al. Autoimmune cholangitis within the spectrum of autoimmune liver disease. Hepatology 2000; 31:1231-1238
8. Hayashi M, Keeffe EB, Krams SM, et al. Allograft rejection after liver transplantation for autoimmune liver disease. Liver Transpl Surg 1998;4:208-214
9. Molmenti EP, Netto GJ, Murray NG, et al. Incidence and recurrence of autoimmune/alloimmune hepatitis in liver transplant recipients. Liver Transpl 2002;8:519-526
10. Czaja AJ. Autoimmune hepatitis after liver transplantation and other lessons of self-intolerance. Liver Transpl 2002;8:505-513
11. Gonza'lez-Koch A, Czaja AJ, Carpenter HA, et al. Recurrent autoimmune hepatitis after orthotopic liver transplantation. Liver Transpl 2001;7:302-310
12. Reich DJ, Fiel I, Guarrera JV, et al. Liver transplantation for autoimmune hepatitis. Hepatology 2000;32:693-700.
13. Harrison RF, Davies MH, Neuberger JM, et al. Fibrous and obliterative cholangitis in liver allografts: evidence of recurrent primary sclerosing cholangitis. Hepatology 1994;20:356-361
14. Graziadei IW, Wiesner RH, Marotta PJ, et al. Long-term results of patients undergoing liver transplantation for primary sclerosing cholangitis. Hepatology 1999;30:1121-1127
15. Goss JA, Shackleton CR, Farmer DG, et al. Orthotopic liver transplantation for primary sclerosing cholangitis. A 12-year single center experience. Ann Surg 1997;225:472-481
16. Angula P, Lindor KD. Primary sclerosing cholangitis. Hepatology 1999;30:325-332
17. International Autoimmune Hepatitis Group. Review of criteria for diagnosis of autoimmune hepatitis [report]. J Hepatol 1999;31: 929-938
18. LaRusso NF, Shneider BI, Black D, et al. Primary sclerosing cholangitis: summary of a workshop. Hepatology 2006;44:746-764
19. Roberts E. Primary sclerosing cholangitis in children. J Gastroenterol Hepatol 1999;14:588-593
20. Floreani A, Rizzotto ER, Ferrara F, et al. Clinical course and outcome of autoimmune hepatitis/primary sclerosing cholangitis. Am J Gastroenterol 2005;100:1516-1522
21. Knodell RG, Ishak KG, Black WC, et al. Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology 1981;1:431-435
22. Demetris AJ, Batts KP, Dhillon AP, et al. Banff Schema for grading liver allograft rejection: an international consensus document. Hepatology 1997;25:658-663
23. Ferrara C, Valeri G, Salvolini L, et al. Magnetic resonance cholangiopancreatography in primary sclerosing cholangitis in children. Pediatr Radiol 2002;32:413-417
24. Majoie CB, Reeders JW, Sanders JB, et al. Primary sclerosing cholangitis: a modified classification of cholangiographic findings. AJR Am J Roentgenol 1991;157:495-497
25. Hubscher SG. Recurrent autoimmune hepatitis after transplantation: diagnostic criteria, risk factor, and outcome. Liver Transpl 2001;7:285-291
26. Evans HM, Kelly DA, McKiernan PJ, et al. Progressive histological damage in liver allografts following pediatric liver transplantation. Hepatology 2006;43:1109-1117
27. Gregorio GV, Portmann B, Reid F, et al. Autoimmune hepatitis in childhood: a 20-year experience. Hepatology 1997;25:541-547
28. Maggiore G, Veber F, Bernard O, et al. Autoimmune hepatitis associated with anti-actin antibodies in children and adolescents. J Pediatr Gastroenterol Nutr 1993;17:376-381
29. Batres LA, Russo P, Mathews M, et al. Primary sclerosing cholangitis in children: a histologic follow-up study. Pediatr Dev Pathol 2005;8:568-576
30. Bambha K, Kim WR, Talwalkar J, et al. Incidence, clinical spectrum, and outcomes of primary sclerosing cholangitis in a United States community. Gastroenterology 2003;125:1364-1369
31. Lindor KD, Kowdley KV, Luketic VA, et al. High-dose ursodeoxycholic acid for the treatment of primary sclerosing cholangitis. Hepatology 2009;50:808-814
32. Brandsaeter B, Isoniemi H, Broome U, et al. Liver transplantation for primary sclerosing cholangitis: predictors and consequences of hepatobiliary malignancy. J Hepatol 2004;40:815-822
33. Bahar RJ, Yanni GS, Martin MG, et al. Orthotopic liver transplantation for autoimmune hepatitis and cryptogenic chronic hepatitis in children. Transplantation 2001;72:829-833
34. Wilschanski M, Chait P, Wade JA, et al. Primary sclerosing cholangitis in 32 children: clinical, laboratory, and radiographic features, with survival analysis. Hepatology 1995;22:1415-1422
35. Gupta P, Hart J, Millis JM, et al. De novo hepatitis with autoimmune antibodies and atypical histology: a rare cause of late graft dysfunction after pediatric liver transplantation. Transplantation 2001;71:664-668
36. Kerkar N, Hadzic N, Davies ET, et al. De-novo autoimmune hepatitis after liver transplantation. Lancet 1998;351:409-413